Fumitoshi Yoshimine
Niigata University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Fumitoshi Yoshimine.
Respirology | 2005
Fumitoshi Yoshimine; Takashi Hasegawa; Eiichi Suzuki; Masaki Terada; Toshiyuki Koya; Ariyoshi Kondoh; Masaaki Arakawa; Hirohisa Yoshizawa; Fumitake Gejyo
Objective: Prevention of deaths due to asthma is one of the most important issues in asthma management. However, there are few epidemiological studies of asthma deaths in Japan.
General Hospital Psychiatry | 2002
Kumiko Muramatsu; Hitoshi Miyaoka; Yoshiyuki Muramatsu; Katsuya Fuse; Fumitoshi Yoshimine; Kunitoshi Kamijima; Fumitake Gejyo; Koji Sakurai
To assess the cultural differences in the role of somatosensory amplification in Japan and North America, we re-examined the role of psychological amplification of objective physical symptoms, as measured by the Somatosensory Amplification Scale (SSAS), in 82 Japanese patients with upper-respiratory tract infections. Anxiety and depression were measured with the Hospital Anxiety and Depression Scale (HADS). We determined the association among continuous variables using the Spearman correlation coefficient. Next, we used multiple regression analysis and selected all symptoms as independent variables. The SSAS was significantly associated with all somatic symptoms. It was also closely related to discomfort, but the SSAS was not significantly correlated with either anxiety or depression. All somatic symptoms were not significantly correlated with the objective physical findings. Multiple regression analyses indicated that amplification by SSAS was a statistically significant predictor of the patients somatic symptoms and discomfort. The objective findings did not significantly predict the patients symptoms. Our study provides some empirical evidence regarding psychological amplification of objective physical symptoms, as measured by SSAS, in Japanese patients with upper-respiratory tract infections. Our findings suggest that there is no difference in the role of amplification of bodily sensations between Japanese and North Americans.
Allergology International | 2012
Takashi Hasegawa; Toshiyuki Koya; Takuro Sakagami; Hiroshi Kagamu; Hidenori Kawakami; Katsuhito Hara; Fumitoshi Yoshimine; Masaaki Arakawa; Fumitake Gejyo; Ichiei Narita; Eiichi Suzuki
BACKGROUND The Asthma Control Test (ACT) is frequently used for the evaluation of asthma control in clinical care setting because it does not require the use of pulmonary function tests, which can be difficult for general practitioners to use. However, few large-scale studies have investigated the efficacy of the Japanese version ACT (J-ACT) in actual use during clinical care. METHODS The aim of this study was to analyze the efficacy of the J-ACT in a clinical care setting. Using data from a 2008 questionnaire survey including the J-ACT by the Niigata Asthma Treatment Study Group, we compared the ACT scores of 2233 patients with respect to multiple parameters, including the severity by Japanese Society of Allergology and the attack frequency. Using the definition of asthma control partially referred to Global Initiative for Asthma (GINA) guidelines from the survey data, the accuracy screening and determination of optimal ACT cutpoints were performed by retrospective analysis. RESULTS Cronbachs α for the J-ACT was 0.785. Patients with more severe asthma and more frequent asthma attacks had lower ACT scores than did patients with less severe, less frequent attacks. The optimal ACT cutpoints were 24 for the controlled asthma and 20 for the uncontrolled asthma. CONCLUSIONS Our study, the first large-scale investigation of the efficacy of the J-ACT, determined that this evaluation tool is highly efficacious in establishing the level of asthma control. However, the determination of accurate cutpoints for the J-ACT will require more clear definitions of asthma control in future prospective studies.
Allergology International | 2011
Mayumi Sasagawa; Takashi Hasegawa; Junichiro James Kazama; Toshiyuki Koya; Takuro Sakagami; Kazuo Suzuki; Katsuhito Hara; Hideo Satoh; Katsuya Fujimori; Fumitoshi Yoshimine; Kazuhiro Satoh; Ichiei Narita; Masaaki Arakawa; Fumitake Gejyo; Eiichi Suzuki
BACKGROUND The effect of inhaled corticosteroid (ICS) on the bone status of asthmatic patients is still uncertain, because it can differ by race and because there have been few cases in Japan. In this study, the bone status of ICS users with asthma was evaluated in an actual clinical setting in Japan. METHODS In 7 participating hospitals, ICS users with asthma and control subjects were age- and gender-matched and recruited into this study. To assess bone status, ultrasound measurements of each individuals calcaneus were made using an AOS-100. The ratio of the osteo sono-assessment index (OSI) to the average OSI corrected for age and gender was denoted as %OSI and used for quantitative assessment. The second %OSI measurement was performed 6 months after the first %OSI one. During the study period, individual treatment remained unchanged. RESULTS There were no significant differences in the 1st and 2nd %OSI between the ICS users and control subjects. However, the 2nd %OSI significantly decreased compared with 1st %OSI in female ICS users, although there were no significant changes in the male and female control subjects and male ICS users. CONCLUSIONS The 6 month management of asthma in the actual clinical setting, including regular ICS use, might have a harmful influence on the bone status of female asthmatic patients. It may be necessary to manage and treat female patients for potent corticosteroid-induced osteoporosis, although further analyses of bone status in asthma patient ICS users will be required.
General Hospital Psychiatry | 2018
Kumiko Muramatsu; Hitoshi Miyaoka; Kunitoshi Kamijima; Yoshiyuki Muramatsu; Yutaka Tanaka; Michio Hosaka; Yusuke Miwa; Katsuya Fuse; Fumitoshi Yoshimine; Ichiro Mashima; Natsue Shimizu; Hiroto Ito; Eiji Shimizu
OBJECTIVE To assess the performance of the Japanese version of the Patient Health Questionnaire-9 (J-PHQ-9) for depression in primary care. METHODS Participants in both phases completed the J-PHQ-9, while patients in the second phase also completed the SF-8 (the short form for the health-related QOL scale SF-36). Subjects (n = 284; male = 107, female = 177) had to return the questionnaires to their health care professional within 48 hours and undergo a diagnostic evaluation interview based on the Japanese version of M.I.N.I-Plus. RESULTS 93 patients were diagnosed as having major depressive disorder (MDD). In the J-PHQ-9, the optimal cutpoint ≥ 10 had sensitivity of 90.5% and specificity of 76.6%. As for the categorical algorithms, the sensitivity was 80.6%; specificity was 89.5%, and a positive likelihood ratio of 7.7. The Stratum-specific likelihood ratios (SSLRs) of the J-PHQ-9 scores of 0-9, 10-14, 15-19, and 20-27 for major depression were 0.10 (95% CI: 0.05-0.20), 1.67 (95% CI: 1.02-2.76), 5.41 (95% CI: 2.87-10.22), and 11.98 (95% CI: 5.39-26.63), respectively. The relationship between the severity of J-PHQ-9 and the MCS of SF-8 was significant (χ 2 = 85.72, df = 4, P ≤ 0.0001). CONCLUSIONS This study has validated the J-PHQ-9 as a useful tool for the assessment of MDD in primary care in Japan.
Internal Medicine | 2019
Toshiyuki Koya; Takashi Hasegawa; Junko Takasawa; Fumitoshi Yoshimine; Takuro Sakagami; Masachika Hayashi; Eiichi Suzuki; Toshiaki Kikuchi
Objective High adherence to medications and accurate handling of inhaler devices are important for asthma management. However, few reports to date have simultaneously evaluated adherence and handling errors. We therefore investigated the adherence to inhaled corticosteroid (ICS) and inhaler handling errors in the same patients in cooperation with pharmacists. Methods Data were derived from a survey of physicians and pharmacists treating asthma patients who visited participating hospitals and pharmacies from July 2012 to January 2013. The patients were evaluated for asthma control using the Asthma Control Test (ACT) and for inhaler handling errors using checklists. ICS adherence was evaluated based on pharmaceutical records. Results Adherence among participants (n=290) was 33.3% (mean), and the percentage of inhaler handling errors was 20.0% (mean). Total inhalation times in the high-adherence group were fewer than those in the low-adherence group. In a comparison by device, adherence to pressurized metered dose inhalers was significantly lower than that to DiskusⓇ inhalers, presumably attributable to the total number of inhalations per day. Adherence, handling errors, and total number of inhalations per day were significantly different between the asthma-controlled group and the uncontrolled group. A multivariate analysis showed that adherence and handling errors were independent factors contributing to asthma control. Conclusion Our data indicated that both adherence to ICS and device handling errors contributed to asthma control in this population.
Nihon Naika Gakkai Zasshi | 2017
Fumitoshi Yoshimine; Katsuhito Hara
新潟青陵大学大学院臨床心理学研究 | 2014
裕 田中; 公美子 村松; 芳幸 村松; 一郎 真島; 健夫 藤村; 夏恵 清水; 洋 清野; 文俊 吉嶺; 浩治 櫻井; 憲司 瀬尾; 等 宮岡; Yutaka Tanaka; Kumiko Muramatsu; Yoshiyuki Muramatsu; Ichiro Mashima; Takeko Fujimura; Natsue Shimizu; Hiroshi Seino; Fumitoshi Yoshimine; Koji Sakurai; Kenji Seo; Hitoshi Miyaoka
american thoracic society international conference | 2012
Fumitoshi Yoshimine; Takashi Hasegawa; Toshiyuki Koya; Takurou Sakagami; Masaaki Arakawa; Fumitake Gejyo; Ichiei Narita; Eiichi Suzuki
american thoracic society international conference | 2012
Takeshi Koizumi; Nao Koshio; Nobumasa Aoki; Akira Youkou; Hiroshi Moro; Yoshinari Tanabe; Eiichi Suzuki; Ichiei Narita; Fumitoshi Yoshimine; Yukiyoshi Kon; Kaoru Suzuki